Your browser doesn't support javascript.
loading
Intravitreal bevacizumab versus combined bevacizumab and triamcinolone acetonide for neovascular age-related macular degeneration
Mohammad, Riazi Esfahani; Hamid, Ahmadieh; Hooshang, Faghihi; Niloofar, Piri; Ramin, Taei; Reza, Karkhaneh; Zahra, Alami Harandi; Alireza, Lashay; Ahmad, Mirshahi; Mehdi, Nili Ahmadabadi; Masoud, Soheilian; Masoumeh, Sanagou.
Journal of Ophthalmic and Vision Research. 2008; 3 (2): 95-101
in En | IMEMR | ID: emr-143556
Responsible library: EMRO
Subject(s)
Search on Google
Add to My VHL
Print
XML
Index: IMEMR Main subject: Aged / Triamcinolone / Visual Acuity / Prospective Studies / Treatment Outcome / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Tomography, Optical Coherence / Drug Therapy, Combination / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J. Ophthalmic Vision Res. Year: 2008
Search on Google
Add to My VHL
Print
XML
Index: IMEMR Main subject: Aged / Triamcinolone / Visual Acuity / Prospective Studies / Treatment Outcome / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Tomography, Optical Coherence / Drug Therapy, Combination / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: J. Ophthalmic Vision Res. Year: 2008